文献速递神经免疫

大型病例对照研究:疫苗接种并非多发性硬化的风险因素

A large case-control study on vaccination as risk factor for multiple sclerosis.
PubMed 文献 · Neurology · 2019-07-30

基于德国巴伐利亚2005-2017年门诊索赔数据,纳入12262例新诊断多发性硬化(MS)患者及多组对照,采用逻辑回归分析首次诊断前5年内的疫苗接种与MS的关联。结果显示有疫苗接种记录者MS的比值比更低,尤其流感疫苗和蜱传脑炎疫苗,结果在不同时间窗和对照队列中一致,不支持疫苗为MS风险因素。

要点

  • 有疫苗接种记录者MS诊断比值比降低(OR 0.870,p<0.001 vs 无自身免疫病对照)。
  • 流感疫苗和蜱传脑炎疫苗与MS诊断的负相关最为明显。
  • 结果在不同时间窗、对照队列和MS定义下一致,不支持疫苗为MS风险因素。

核心结论

  • 本研究未发现疫苗接种是多发性硬化的风险因素,反而一致提示接种疫苗与未来5年内被诊断MS的可能性降低。
  • 这种关联是否为保护效应尚需未来研究验证。

研究设计与样本

  • 基于德国巴伐利亚法定健康保险医师协会2005-2017年门诊索赔数据的病例对照研究。
  • 采用逻辑回归模型评估首次诊断前5年内疫苗接种与MS的关联。
  • MS患者n=12,262;对照包括新诊断克罗恩病n=19,296、银屑病n=112,292及无自身免疫病史者n=79,185。

主要发现

  • 有疫苗接种记录者MS的比值比更低:vs无自身免疫病对照OR 0.870(p<0.001);vs克罗恩病对照OR 0.919(p<0.001);vs银屑病对照OR 0.973(p=0.177)。
  • 流感疫苗和蜱传脑炎疫苗的负相关最为明显。
  • 效应在不同时间窗、对照队列和MS队列定义下一致,且效应量随接近首次诊断时间而增大。

关键数值与推荐

  • MS患者n=12,262;克罗恩病对照n=19,296;银屑病对照n=112,292;无自身免疫病对照n=79,185。
  • 有疫苗接种记录 vs 无自身免疫病对照:OR 0.870,p<0.001。
  • 有疫苗接种记录 vs 克罗恩病对照:OR 0.919,p<0.001。
  • 有疫苗接种记录 vs 银屑病对照:OR 0.973,p=0.177。

临床怎么用

  • 临床沟通中可参考本研究结果,向患者说明疫苗接种未显示增加MS风险。
  • 对于MS风险担忧的患者,可提及流感疫苗和蜱传脑炎疫苗与MS诊断负相关,但保护效应未确立。

局限性

  • 基于索赔数据的病例对照研究,可能存在未测量的混杂因素。
  • 疫苗接种记录可能不完整或存在分类错误。
  • 关联不能推断因果关系,保护效应需未来研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the hypothesis that vaccination is a risk factor for multiple sclerosis (MS) by use of German ambulatory claims data in a case-control study. METHODS: Using the ambulatory claims data of the Bavarian Association of Statutory Health Insurance Physicians covering 2005-2017, logistic regression models were used to assess the relation between MS (n = 12,262) and vaccinations in the 5 years before first diagnosis. Participants newly diagnosed with Crohn disease (n = 19,296) or psoriasis (n = 112,292) and participants with no history of these autoimmune diseases (n = 79,185) served as controls. RESULTS: The odds of MS were lower in participants with a recorded vaccination (odds ratio [OR] 0.870, p < 0.001 vs participants without autoimmune disease; OR 0.919, p < 0.001 vs participants with Crohn disease; OR 0.973, p = 0.177 vs participants with psoriasis). Lower odds were most pronounced for vaccinations against influenza and tick-borne encephalitis. These effects were consistently observed for different time frames, control cohorts, and definitions of the MS cohort. Effect sizes increased toward the time of first diagnosis. CONCLUSIONS: Results of the present study do not reveal vaccination to be a risk factor for MS. On the contrary, they consistently suggest that vaccination is associated with a lower likelihood of being diagnosed with MS within the next 5 years. Whether this is a protective effect needs to be addressed by future studies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hapfelmeier A, Gasperi C, Donnachie E, et al. A large case-control study on vaccination as risk factor for multiple sclerosis. Neurology. 2019. PMID: 31363057. doi:10.1212/WNL.0000000000008012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。